Investor Presentation First Nine Months of 2022
Novo NordiskⓇ
155
Investor presentation First nine months of 2022
Novo Nordisk pledges to reach net-zero emissions across the
entire value chain by 2045
Reporting CO₂ emissions across scopes in the Company Announcement 9M 2022
9M 2019 total: 227t
9M 2021 total: 127t
9M 2022 total: 186t
18%
vs. 9M 20191
↓
Key initiatives to reduce CO2 emissions across all three scopes
Scope 1 - Direct emissions from own sources (16% reduction¹)
Company cars: Target of 100% electric or plug-in hybrid electric cars
by 2030
64
56
54
55
107
12
12
59
120
9M 2019 9M 2021 9M 2022
9M 2019 9M 2021 9M 2022
9M 2019 9M 2021 9M 2022
O
Scope 1
Scope 2
Partial scope 32
CO2 emissions, 1,000 tonnes
Scope 2 - Indirect emissions from purchased energy (78%
reduction¹)
•
Production: Sourcing 100% of renewable power at sites since 2020
•
Partial scope 3 - Other emissions across value chain (12% increase¹)
Suppliers: Commitment from direct suppliers to use renewable
power
Product distribution: Partnership with Mærsk using biofuel and
partnership with Kuehne+Nagel (2022) and SkyNRG (2025) using
Sustainable Aviation Fuel when transporting Novo Nordisk products
12019 used as baseline across the scopes given the impact of COVID-19 in 2020. 2Novo Nordisk's reporting of Scope 3 emissions is currently limited to product distribution and business flights implying that the data shown do not include a significant proportion of
Scope 3 emissions from Novo Nordisk's supply chain.View entire presentation